Site icon Alpha Edge Investing

DBS: Morgan Stanley – Buy Target Price USD90.00

3Q23 profit down 9% amid Investment banking slump

Investment banking slump.  3Q23 earnings were down 9% y-o-y to reach US$2.4b.  Despite that earnings were slightly ahead of consensus’ US$2.3b, the weaker-than-expected investment banking revenues (-27% y-o-y) and the slower wealth management inflows (-45% q-o-q) were disappointing.  Wealth management net interest income was down US$0.2bn or 9% q-o-q due to higher average cost of deposit (+37bps q-o-q), which also weighed on profit.  Trading businesses were more resilient, with revenue from equities and FICC businesses up 2% y-o-y and down 11% y-o-y respectively.  Capital front was stable with CET1 ratio at 15.5%, after completing US$1.5b of share repurchase during the quarter.  The company also declared quarterly dividend per share of US$0.85, implying a c.4% annualised yield.  

Solid business momentum while awaiting the end of rate hike.  The higher-for-longer interest rates have inevitably weighed on the company’s performance.  Despite seeing pent-up investment banking activities, the corporates are still awaiting for more clarity on cost-of-financing to pull the trigger.  The shift in deposit mix has also continued led to NIM contraction.  The 4-5% cash return also has discouraged customer from trading and increasing allocation to risky assets, which weighed on the fees as well.  On a positive note, the company has seen higher M&A announcement during the quarter which should convert to revenues in 1H24.  It has also finally completed the integration of e-Trade, and the revenue synergy should gradually surface and reinforce Morgan Stanley’s strong wealth franchise.  Maintain BUY with a lower TP of US$90, pegged to 1.5x FY24F P/B, to reflect the increased pressure seen from higher interest rates.  

Exit mobile version